-

- (-%)

BURZYNSKI RESEARCH INSTITUTE INC [BZYR]

Source: 

Company Overview

Burzynski Research Institute (BRI) is a biopharmaceutical company committed to developing, and delivering cancer therapies based on genomic and epigenomic principles. Currently research and development efforts are focused on investigational agents called Antineoplastons (ANPs) and their efficacy and safety in the treatment of advanced cancers, especially malignant brain tumors. ANPs have been investigated in phase I and II clinical trials.

CountryUS
Headquartershoustontexas
Phone Number(713) 335-5697
Industryin vitro & in vivo diagnostic substances
CEOStanislaw R. Burzynski
Websiteburzynskiresearch.com

Recent Stories